A pharmacokinetic-viral kinetic model describes the effect of alisporivir as monotherapy or in combination with peg-IFN on hepatitis C virologic response.
Clinical pharmacology and therapeutics | 2014-11-01 | PMID 25166216
Nguyen T H T, Mentré F, Levi M and 2 more
